S. Bekri, Diagnostic Biologique des Maladies Lysosomales, Annale de Biologie Clinique, vol.64, pp.592-600, 2006.

S. Walkley, Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome, Acta Paediatrica, vol.1, pp.26-32, 2007.
DOI : 10.1111/j.1651-2227.2007.00202.x

A. Vellodi, Lysosomal storage disorders, British Journal of Haematology, vol.24, issue.Part 9, pp.413-444, 2005.
DOI : 10.1111/j.1365-2141.2004.05293.x

A. Novikoff, P. Novikoff, N. Quintana, and . Dc, STUDIES ON MICROPEROXISOMES IV. INTERRELATIONS OF MICROPEROXISOMES, ENDOPLASMIC RETICULUM AND LIPOFUSCIN GRANULES, Journal of Histochemistry & Cytochemistry, vol.21, issue.11, pp.1010-1030, 1973.
DOI : 10.1177/21.11.1010

M. Huizing, A. Helip-wooley, W. Westbroek, M. Gunay-aygun, and W. Gahl, Disorders of Lysosome-Related Organelle Biogenesis: Clinical and Molecular Genetics, Annual Review of Genomics and Human Genetics, vol.9, issue.1, pp.359-86, 2008.
DOI : 10.1146/annurev.genom.9.081307.164303

R. Nixon, P. Mathews, and A. Cataldo, The neuronal endosomal-lysosomal system in Alzheimer's disease, Journal of Alzheimer's Disease, vol.3, issue.1, pp.97-107, 2001.
DOI : 10.3233/JAD-2001-3114

R. Garnotel, Biochimie du lysosome: Place des cibles thérapeutiques, Annale de Biologie Clinique, vol.64, pp.590-592, 2006.

P. Saftig and J. Klumperman, Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function, Nature Reviews Molecular Cell Biology, vol.180, issue.9, pp.623-658, 2009.
DOI : 10.1083/jcb.200210166

J. Luzio, B. Rous, N. Bright, P. Pryor, B. Mullock et al., Lysosome-endosome fusion and lysosome biogenesis, Journal of cell science, vol.113, pp.1515-1539, 2000.

A. Morgan, F. Platt, E. Lloyd-evans, and A. Galione, signalling in health and disease, Biochemical Journal, vol.109, issue.3, pp.349-74, 2011.
DOI : 10.1073/pnas.93.19.10510

A. Reddy, E. Caler, N. Andrews, and N. Haven, Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes, Cell, vol.106, issue.2, pp.157-69, 2001.
DOI : 10.1016/S0092-8674(01)00421-4

P. Boya, Lysosomal Function and Dysfunction: Mechanism and Disease, Antioxidants & Redox Signaling, vol.17, issue.5, pp.766-74, 2012.
DOI : 10.1089/ars.2011.4405

C. Watts, The endosome???lysosome pathway and information generation in the immune system, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1824, issue.1, pp.14-21, 2012.
DOI : 10.1016/j.bbapap.2011.07.006

A. Aqul, B. Liu, M. Ramirez, and C. , Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment, Journal of Neuroscience, vol.31, issue.25, pp.9404-9417, 2011.
DOI : 10.1523/JNEUROSCI.1317-11.2011

T. Braulke and J. Bonifacino, Sorting of lysosomal proteins, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.605-619, 2009.
DOI : 10.1016/j.bbamcr.2008.10.016

J. Glickman and S. Kornfeld, Mannose 6-phosphate-independent targeting of lysosomal enzymes in I- cell disease B lymphoblasts, The Journal of Cell Biology, vol.123, issue.1, pp.99-108, 1993.
DOI : 10.1083/jcb.123.1.99

K. Elvevold, J. Simon-santamaria, H. Hasvold, P. Mccourt, B. Smedsrød et al., Liver sinusoidal endothelial cells depend on mannose receptor-mediated recruitment of lysosomal enzymes for normal degradation capacity, Hepatology, vol.306, issue.Pt 10, 2008.
DOI : 10.1002/hep.22527

S. Lefrancois, J. Zeng, A. Hassan, M. Canuel, and C. Morales, The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin, The EMBO Journal, vol.19, issue.24, pp.6430-6437, 2003.
DOI : 10.1126/science.1060896

X. Ni and C. Morales, The Lysosomal Trafficking of Acid Sphingomyelinase is Mediated by Sortilin and Mannose 6-phosphate Receptor, Traffic, vol.922, issue.7, pp.889-902, 2006.
DOI : 10.1111/j.1600-0854.2006.00429.x

D. Reczek, M. Schwake, and J. Schröder, LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of ??-Glucocerebrosidase, Cell, vol.131, issue.4, pp.770-83, 2007.
DOI : 10.1016/j.cell.2007.10.018

E. Eskelinen, Y. Tanaka, and P. Saftig, At the acidic edge: emerging functions for lysosomal membrane proteins, Trends in Cell Biology, vol.13, issue.3, pp.137-182, 2003.
DOI : 10.1016/S0962-8924(03)00005-9

S. Bellier, Les maladies lysosomales de l’homme et des animaux domestiques, Revue de Médecine Vétérinaire, vol.152, pp.435-481, 2001.

C. Huxtable and P. Dorling, Animal model of human disease. Mannosidosis. Swainsonineinduced mannosidosis, American Journal Of Pathology, vol.107, pp.124-130, 1982.

H. Neville, C. Maunder-sewry, J. Mcdougall, J. Sewell, and . Dv, Chloroquine-induced cytosomes with curvilinear profiles in muscle, Muscle & Nerve, vol.50, issue.5, pp.376-81, 1979.
DOI : 10.1002/mus.880020509

J. Lee, W. Chung, and J. Kang, A Case of Chloroquine-Induced Cardiomyopathy That Presented as Sick Sinus Syndrome, Korean Circulation Journal, vol.40, issue.11, pp.604-612, 2010.
DOI : 10.4070/kcj.2010.40.11.604

O. Staretz-chacham, T. Lang, M. Lamarca, D. Krasnewich, and E. Sidransky, Lysosomal Storage Disorders in the Newborn, PEDIATRICS, vol.123, issue.4, pp.1191-207, 2009.
DOI : 10.1542/peds.2008-0635

E. Parkinson-lawrence, T. Shandala, M. Prodoehl, R. Plew, G. Borlace et al., Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology, Physiology, vol.25, issue.2, pp.102-117, 2010.
DOI : 10.1152/physiol.00041.2009

H. Poupetová, J. Ledvinová, L. Berná, L. Dvoráková, V. Kozich et al., The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations, Journal of Inherited Metabolic Disease, vol.93, issue.2, pp.387-96, 2010.
DOI : 10.1007/s10545-010-9093-7

M. Filocamo, A. Morrone, P. Metaboliche, D. Neuroscienze, I. Gaslini et al., Lysosomal storage disorders: Molecular basis and laboratory testing, Human Genomics, vol.5, issue.3, pp.156-69, 2011.
DOI : 10.1136/jmg.2004.029744

W. Wilcox, Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care, The Journal of Pediatrics, vol.144, issue.5, pp.3-14, 2004.
DOI : 10.1016/j.jpeds.2004.01.049

A. Ballabio and V. Gieselmann, Lysosomal disorders: From storage to cellular damage, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.684-96, 2009.
DOI : 10.1016/j.bbamcr.2008.12.001

R. Ruivo, C. Anne, C. Sagné, and B. Gasnier, Molecular and cellular basis of lysosomal transmembrane protein dysfunction, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.636-685, 2009.
DOI : 10.1016/j.bbamcr.2008.12.008

URL : https://hal.archives-ouvertes.fr/hal-00415318

T. Dierks, L. Schlotawa, M. Frese, K. Radhakrishnan, K. Figura et al., Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann???Pick C1 disease ??? Lysosomal storage disorders caused by defects of non-lysosomal proteins, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.710-735, 2009.
DOI : 10.1016/j.bbamcr.2008.11.015

R. Tamargo, A. Velayati, E. Goldin, and E. Sidransky, The role of saposin C in Gaucher disease, Molecular Genetics and Metabolism, vol.106, issue.3, pp.257-63, 2012.
DOI : 10.1016/j.ymgme.2012.04.024

S. Ishibashi, T. Yamazaki, and K. Okamoto, Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells, Journal of Clinical Neuroscience, vol.16, issue.7, pp.954-963, 2009.
DOI : 10.1016/j.jocn.2008.09.020

D. Purpura and A. Einstein, Pathogenic cascades in lysosomal disease-Why so complex, Journal of inherited metabolic disease, vol.32, pp.181-190, 2009.

M. Schultz, L. Tecedor, M. Chang, and B. Davidson, Clarifying lysosomal storage diseases, Trends in Neurosciences, vol.34, issue.8, pp.401-411, 2011.
DOI : 10.1016/j.tins.2011.05.006

E. Vitner, F. Platt, and A. Futerman, Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases: TABLE 1, Journal of Biological Chemistry, vol.285, issue.27, pp.20423-20430, 2010.
DOI : 10.1074/jbc.R110.134452

M. Jmoudiak and A. Futerman, Gaucher disease: pathological mechanisms and modern management, British Journal of Haematology, vol.41, issue.2, pp.178-88, 2005.
DOI : 10.1016/S0140-6736(89)90536-9

M. Jeyakumar, Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis, Brain, vol.126, issue.4, pp.974-87, 2003.
DOI : 10.1093/brain/awg089

D. Smith, K. Wallom, I. Williams, M. Jeyakumar, and F. Platt, Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1, Neurobiology of Disease, vol.36, issue.2, pp.242-51, 2009.
DOI : 10.1016/j.nbd.2009.07.010

H. Wei, S. Kim, Z. Zhang, P. Tsai, K. Wisniewski et al., ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones, Human Molecular Genetics, vol.17, issue.4, pp.469-77, 2008.
DOI : 10.1093/hmg/ddm324

A. Futerman and G. Van-meer, The cell biology of lysosomal storage disorders, Nature Reviews Molecular Cell Biology, vol.141, issue.7, pp.554-65, 2004.
DOI : 10.1073/pnas.0308456101

F. Platt and R. Lachmann, Treating lysosomal storage disorders: Current practice and future prospects, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.737-782, 2009.
DOI : 10.1016/j.bbamcr.2008.08.009

L. Astarita, M. Sibilio, and A. Generoso, Lysosomal storage disorders$: commonalities and differences, Lysosomal storage diseases, pp.3-12, 2010.

B. Héron and G. Guffon, Progrès dans les maladies lysosomales, Maladies métaboliques héréditaires. , Progrès en pédiatrie, pp.25-55, 2011.

M. Maier-redelsperger and O. Fenneteau, Aspects cytologiques des maladies de surcharge lysosomale, Revue Fran??aise des Laboratoires, vol.1998, issue.303, pp.31-36, 1998.
DOI : 10.1016/S0338-9898(98)80064-4

C. Groote, Extracerebral Biopsy in Lysosomal and Peroxisomal Disorders, Ultrastructural Findings. brain pathology, vol.8, pp.121-153, 1998.

G. Ruijter, Mucopolysaccharidoses diagnostic approaches, 2012.

D. Jong, J. Wevers, R. Laarakkers, C. Poorthuis, and B. , Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses, Clinical chemistry, vol.35, pp.1472-1479, 1989.

G. Gray, P. Claridge, L. Jenkinson, and A. Green, Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses ??? an evaluation, Annals of Clinical Biochemistry, vol.44, issue.4, pp.360-363, 2007.
DOI : 10.1258/000456307780945688

S. Tomatsu, M. Gutierrez, and T. Ishimaru, Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses, Journal of Inherited Metabolic Disease, vol.177, issue.4, pp.743-57, 2005.
DOI : 10.1007/s10545-005-0069-y

C. Auray-blais, P. Bhérer, and R. Gagnon, Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Molecular genetics and metabolism, pp.49-56, 2011.

M. Fuller, T. Rozaklis, S. Ramsay, J. Hopwood, and P. Meikle, Disease-Specific Markers for the Mucopolysaccharidoses, Pediatric Research, vol.118, issue.5, pp.733-741, 2004.
DOI : 10.1203/01.PDR.0000141987.69757.DD

S. Tomatsu, A. Montaño, and T. Oguma, Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry, Molecular Genetics and Metabolism, vol.99, issue.2, pp.124-155, 2010.
DOI : 10.1016/j.ymgme.2009.10.001

P. Mabe, A. Valiente, V. Soto, V. Cornejo, and E. Raimann, Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests, Clinica Chimica Acta, vol.345, issue.1-2, pp.135-175, 2004.
DOI : 10.1016/j.cccn.2004.03.015

C. Regnery, C. Kornblum, and F. Hanisch, 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy, Journal of Inherited Metabolic Disease, vol.104, issue.3, 2012.
DOI : 10.1007/s10545-012-9451-8

J. Sheth, F. Sheth, N. Oza, P. Gambhir, U. Dave et al., Plasma chitotriosidase activity in children with lysosomal storage disorders, The Indian Journal of Pediatrics, vol.273, issue.2, pp.203-208, 2010.
DOI : 10.1007/s12098-009-0249-0

Y. Budak, K. Huysal, and A. Guray, Urinary glycosaminoglycan excretion in patients with primary nocturnal enuresis, Italian Journal of Pediatrics, vol.36, issue.1, p.13, 2010.
DOI : 10.1186/1824-7288-36-13

V. Gieselmann, What can cell biology tell us about heterogeneity in lysosomal storage diseases?, Acta Paediatrica, vol.94, pp.80-86, 2005.

G. Thomas, “Pseudodeficiencies” of lysosomal hydrolases, American journal of human genetics, vol.54, pp.934-974, 1994.

S. Leistner, E. Young, C. Meaney, and B. Winchester, Pseudodeficiency of arylsulphatase A: Strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms, Journal of Inherited Metabolic Disease, vol.52, issue.6, pp.710-716, 1995.
DOI : 10.1007/BF02436761

I. Maire, Diagnostic biologique et mol??culaire des maladies de surcharge lysosomale, Revue Fran??aise des Laboratoires, vol.1998, issue.303, pp.37-40, 1998.
DOI : 10.1016/S0338-9898(98)80065-6

M. Kroos, M. Hoogeveen-westerveld, V. D. Ploeg, A. Reuser, and A. , The genotype-phenotype correlation in Pompe disease, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.19, issue.1, pp.59-68, 2012.
DOI : 10.1002/ajmg.c.31318

N. Terlato and G. Cox, Can mucopolysaccharidosis type I disease severity be predicted based on a patient???s genotype? A comprehensive review of the literature, Genetics in Medicine, vol.11, issue.4, pp.286-94, 2003.
DOI : 10.1097/01.GIM.0000078027.83236.49

S. Blanchard, M. Sadilek, R. Scott, F. Turecek, and M. Gelb, Tandem Mass Spectrometry for the Direct Assay of Lysosomal Enzymes in Dried Blood Spots: Application to Screening Newborns for Mucopolysaccharidosis I, Clinical Chemistry, vol.54, issue.12, pp.2067-70, 2010.
DOI : 10.1373/clinchem.2008.115410

J. Orsini, M. Martin, and A. Showers, Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disorders, Clinica Chimica Acta, vol.413, issue.15-16, pp.1270-1273, 2012.
DOI : 10.1016/j.cca.2012.04.012

S. Paciotti, E. Persichetti, and S. Pagliardini, First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene, Clinica Chimica Acta, vol.413, issue.23-24, pp.1827-1858, 2012.
DOI : 10.1016/j.cca.2012.07.011

C. Pennock and I. Barnes, The mucopolysaccharidoses., Journal of Medical Genetics, vol.13, issue.3, pp.169-81, 1976.
DOI : 10.1136/jmg.13.3.169

N. Sharma, R. Singh, and J. Anand, Hurler???s syndrome, The Indian Journal of Pediatrics, vol.33, issue.9, pp.301-307, 1965.
DOI : 10.1007/BF02756497

V. Mckusick, THE GENETIC MUCOPOLYSACCHARIDOSES, Medicine, vol.44, issue.6, pp.1-4, 1965.
DOI : 10.1097/00005792-196511000-00001

H. Scott, D. Anson, and A. Orsborn, Human alpha-L-iduronidase: cDNA isolation and expression., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9695-9704, 1991.
DOI : 10.1073/pnas.88.21.9695

H. Scott, T. Litjens, and P. Nelson, Identification of Mutations in the a-L-lduronidase Gene ( IDUA ) That Cause Hurler and Scheie Syndromes, American journal of human genetics, vol.53, pp.973-86, 1993.

R. Shull, E. Kakkis, M. Mcentee, S. Kania, A. Jonas et al., Enzyme replacement in a canine model of Hurler syndrome., Proceedings of the National Academy of Sciences, vol.91, issue.26, pp.12937-12978, 1994.
DOI : 10.1073/pnas.91.26.12937

E. Kakkis, M. Mcentee, and A. Schmidtchen, Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis I, Biochemical and Molecular Medicine, vol.58, issue.2, pp.156-67, 1996.
DOI : 10.1006/bmme.1996.0044

E. Kakkis, E. Schuchman, and X. He, Enzyme replacement therapy in feline mucopolysaccharidosis I. Molecular genetics and metabolism, 2001.

E. Kakkis, J. Muenzer, and G. Tiller, Enzyme-Replacement Therapy in Mucopolysaccharidosis I, New England Journal of Medicine, vol.344, issue.3, pp.182-190, 2001.
DOI : 10.1056/NEJM200101183440304

L. Cahiers and D. , Prévalence des maladies rares: Données bibliographiques, pp.1-30, 2012.

K. Krabbi, K. Joost, R. Zordania, I. Talvik, R. Rein et al., The livebirth prevalence of mucopolysaccharidoses in estonia, Protocole National De Diagnostic et De Soins, 2007.

K. D’aco, L. Underhill, and L. Rangachari, Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry, European Journal of Pediatrics, vol.154, issue.859???864, pp.911-920, 2012.
DOI : 10.1007/s00431-011-1644-x

A. Murphy, D. Lambert, E. Treacy, A. O’meara, and S. Lynch, Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic, Archives of Disease in Childhood, vol.94, issue.1, pp.52-56, 2009.
DOI : 10.1136/adc.2007.135772

A. Vazna, C. Beesley, and L. Berna, Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein, American Journal of Medical Genetics Part A, vol.15, issue.5, pp.965-74, 2009.
DOI : 10.1002/ajmg.a.32812

G. Malm, A. Lund, J. Månsson, and A. Heiberg, Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence, Acta Paediatrica, vol.102, issue.11, pp.1577-81, 2008.
DOI : 10.1111/j.1651-2227.2008.00965.x

D. Moore, M. Connock, E. Wraith, and C. Lavery, The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.24, 2008.
DOI : 10.1186/1750-1172-3-24

A. Al-maawali, S. Joshi, and R. Koul, Spectrum of Paediatric Lysosomal Storage Disorders in Oman = ?????? ???????????????? ???????????????? ???? ???????????????? ???????????? ?????? ?????????????? ???? ????????, Sultan Qaboos University Medical Journal, vol.12, issue.3, pp.295-304, 2012.
DOI : 10.12816/0003142

J. Muenzer, J. Wraith, and L. Clarke, Mucopolysaccharidosis I: Management and Treatment Guidelines, PEDIATRICS, vol.123, issue.1, pp.19-29, 2009.
DOI : 10.1542/peds.2008-0416

A. Martins, A. Dualibi, and D. Norato, Guidelines for the Management of Mucopolysaccharidosis Type I, The Journal of Pediatrics, vol.155, issue.4, pp.32-46, 2009.
DOI : 10.1016/j.jpeds.2009.07.005

J. Muenzer, The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations, The Journal of Pediatrics, vol.144, issue.5, pp.27-34, 2004.
DOI : 10.1016/j.jpeds.2004.01.052

K. Kirkpatrick, E. J. Walker, and R. , Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management, Pediatric Anesthesia, vol.13, issue.8, pp.745-51, 2012.
DOI : 10.1111/j.1460-9592.2012.03897.x

J. Thomas, M. Beck, J. Clarke, and G. Cox, Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I, Journal of Inherited Metabolic Disease, vol.144, issue.5, pp.421-428, 2010.
DOI : 10.1007/s10545-010-9113-7

P. Arn, C. Whitley, and J. Wraith, High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry, Journal of Pediatric Surgery, vol.47, issue.3, pp.477-84, 2012.
DOI : 10.1016/j.jpedsurg.2011.09.042

M. Brands, I. Frohn-mulder, and M. Hagemans, Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI, Journal of Inherited Metabolic Disease, vol.16, issue.2, 2012.
DOI : 10.1007/s10545-011-9444-z

W. Nyhan, P. Ozland, and B. Barshop, Atlas of Metabolic Diseases, 2005.

O. Bodamer, Clinical Characteristics of MPS I Patients in the MPS I Registry. The American Society of, Human Genetics, 2007.

M. De-ru, Q. Teunissen, and J. Lee, Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.22, 2012.
DOI : 10.1186/1750-1172-7-22

P. Arn, J. Wraith, and L. Underhill, Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry, The Journal of Pediatrics, vol.154, issue.6, pp.859-64, 2009.
DOI : 10.1016/j.jpeds.2008.12.024

M. Aldenhoven, T. De-koning, and F. Verheijen, Dried Blood Spot Analysis: An Easy and Reliable Tool to Monitor the Biochemical Effect of Hematopoietic Stem Cell Transplantation in Hurler Syndrome Patients, Biology of Blood and Marrow Transplantation, vol.16, issue.5, pp.701-705, 2010.
DOI : 10.1016/j.bbmt.2010.01.006

E. Aronovich, D. Pan, and C. Whitley, Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency, American journal of human genetics, vol.58, pp.75-85, 1996.

F. Bertola, M. Filocamo, and G. Casati, IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel ??-L-iduronidase (IDUA) alleles, Human Mutation, vol.32, issue.6, pp.2189-210, 2011.
DOI : 10.1002/humu.21479

URL : https://hal.archives-ouvertes.fr/hal-00621299

G. Cox, J. Wraith, C. Whitley, F. Wijburg, and N. Guffon, 31. Genotype frequencies in the MPS I Registry, Molecular Genetics and Metabolism, vol.96, issue.2, p.19, 2009.
DOI : 10.1016/j.ymgme.2008.11.032

E. Voskoboeva, X. Krasnopolskaya, T. Mirenburg, B. Weber, and J. Hopwood, Molecular Genetics of Mucopolysaccharidosis Type I: Mutation Analysis among the Patients of the Former Soviet Union, Molecular Genetics and Metabolism, vol.65, issue.2, pp.174-80, 1998.
DOI : 10.1006/mgme.1998.2745

N. Alif, K. Hess, J. Straczek, S. Sebbar, A. Bou et al., Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects, Annals of Human Genetics, vol.63, issue.1, pp.9-16, 1999.
DOI : 10.1046/j.1469-1809.1999.6310009.x

L. Chkioua, S. Khedhiri, and A. Kassab, Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms, Diagnostic Pathology, vol.6, issue.1, p.39, 2011.
DOI : 10.1186/1746-1596-6-11

L. Hein, J. Hopwood, P. Clements, and D. Brooks, The ??-l-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1639, issue.2, pp.95-103, 2003.
DOI : 10.1016/S0925-4439(03)00129-7

S. Bunge, P. Clements, S. Byers, W. Kleijer, D. Brooks et al., Genotype???phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1407, issue.3, pp.249-56, 1998.
DOI : 10.1016/S0925-4439(98)00046-5

F. Children, C. Peters, and E. Shapiro, Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four Children, Blood Cells, vol.91, pp.2601-2609, 1998.

L. Clarke, J. Wraith, and M. Beck, Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I, PEDIATRICS, vol.123, issue.1, pp.229-269, 2009.
DOI : 10.1542/peds.2007-3847

J. Wraith, M. Beck, and R. Lane, Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human ??-L-Iduronidase (Laronidase), PEDIATRICS, vol.120, issue.1, pp.37-46, 2007.
DOI : 10.1542/peds.2006-2156

P. Dickson, N. Ellinwood, and J. Brown, Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I. Molecular genetics and metabolism 2012, pp.68-72

S. Shah, J. Jens, and E. Snella, Replacing the Enzyme !-L-Iduronidase at Birth Ameliorates Symptoms in the Brain and Periphery of Dogs with Mucopolysaccharidosis Type I, Science Translational Medecine, vol.2, pp.1-18, 2011.

U. Matte, V. Lagranha, T. De-carvalho, F. Mayer, and R. Giugliani, Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases, Journal of Inherited Metabolic Disease, vol.72, issue.2, pp.983-90, 2011.
DOI : 10.1007/s10545-011-9350-4

D. Ru, M. Boelens, J. Das, and A. , Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure, Orphanet journal of rare diseases, vol.6, p.55, 2011.

V. Valayannopoulos and F. Wijburg, Therapy for the mucopolysaccharidoses, Rheumatology, vol.50, issue.suppl 5, pp.49-59, 2011.
DOI : 10.1093/rheumatology/ker396

D. Brooks, V. Muller, and J. Hopwood, Stop-codon read-through for patients affected by a lysosomal storage disorder, Trends in Molecular Medicine, vol.12, issue.8, pp.367-73, 2006.
DOI : 10.1016/j.molmed.2006.06.001

L. Chkioua, S. Khedhiri, and Z. Jaidane, La mucopolysaccharidose de??type I: identification des??mutations du??g??ne alpha-L-iduronidase dans??des??familles tunisiennes, Archives de P??diatrie, vol.14, issue.10, pp.1183-1192, 2007.
DOI : 10.1016/j.arcped.2007.06.018

L. Chkioua, S. Khedhiri, and H. Turkia, Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients, Diagnostic Pathology, vol.6, issue.1, p.47, 2011.
DOI : 10.1186/1746-1596-6-11

X. Wang, W. Zhang, and H. Shi, Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis, Clinical Genetics, vol.2, issue.8, pp.443-52, 2012.
DOI : 10.1111/j.1399-0004.2011.01680.x

J. Ashworth, S. Biswas, E. Wraith, and I. Lloyd, The ocular features of the mucopolysaccharidoses, Eye, vol.96, issue.5, pp.553-63, 2006.
DOI : 10.1016/S0161-6420(98)96014-6

R. Giugliani, V. Rojas, and A. Martins, A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I. Molecular genetics and metabolism, pp.13-22, 2009.

A. Jurecka, Z. Zuber, V. Opoka-winiarska, G. W&grzyn, and *. Tylki-szyma, Effect of rapid cessation of enzyme replacement therapy: A report of 5 cases and a review of the literature. Molecular genetics and metabolism 2012

B. Imessaoudene, S. Hallal, M. Ghouali, and A. Berhoune, La maladie de Hurler: ?? propos de 30 cas, Revue Francophone des Laboratoires, vol.2011, issue.436, pp.73-79, 2011.
DOI : 10.1016/S1773-035X(11)71159-5

A. Almeida, G. Pasqualim, and F. Mayer, Analysis of cDNA Molecules is Not Suitable for the Molecular Diagnosis of Mucopolysaccharidosis Type I, Diagnostic Molecular Pathology, vol.21, issue.1, pp.53-58, 2012.
DOI : 10.1097/PDM.0b013e318230f021

U. Matte, G. Yogalingam, and D. Brooks, Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients, Molecular Genetics and Metabolism, vol.78, issue.1, pp.37-43, 2003.
DOI : 10.1016/S1096-7192(02)00200-7

H. Scott, T. Litjens, and P. Nelson, Alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype, Human mutation, vol.339, pp.333-342, 1992.

. Yamagishi-a, S. Tomatsu, and S. Fukuda, Mucopolysaccharidosis type I: Identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations, Human Mutation, vol.95, issue.1, pp.23-32, 1996.
DOI : 10.1002/(SICI)1098-1004(1996)7:1<23::AID-HUMU3>3.0.CO;2-Q

N. Venturi, A. Rovelli, and R. Parini, Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations, Human Mutation, vol.20, issue.3, p.231, 2002.
DOI : 10.1002/humu.9051

C. Beesley, C. Meaney, and G. Greenland, Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations, Human genetics, vol.109, pp.503-514, 2001.

P. Li, T. Wood, and J. Thompson, Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human ??-l-iduronidase (IDUA) gene, Genetics in Medicine, vol.58, issue.6, pp.420-426, 2002.
DOI : 10.1097/00125817-200211000-00004